Journal article
Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer.
Abstract
BACKGROUND: Longitudinal quality of life (QoL) was compared for patients with esophageal cancer receiving definitive chemoradiotherapy (CRT) with conventional-dose (CD) vs. high-dose (HD) radiotherapy as used in the RTOG phase III 94-05 trial (Intergroup 0123).
METHODS: Between June 12, 1995, and July 1, 1999, 236 patients with cT1-4NxM0 esophageal cancer were randomized to CD CRT (50.4 Gy and concurrent 5-fluorouracil and cisplatin) vs. HD CRT …
Authors
Kachnic LA; Winter K; Wasserman T; Kelsen D; Ginsberg R; Pisansky TM; Martenson J; Komaki R; Okawara G; Rosenthal SA
Journal
Gastrointestinal cancer research : GCR, Vol. 4, No. 2, pp. 45–52
Publication Date
March 2011
ISSN
1934-7820